Solvay
has broadened its portfolio of high-performance filaments for premium
additive manufacturing (AM) applications with the introduction of three
medical grade products for use in the healthcare industry.
A neat KetaSpire® polyetheretherketone (PEEK) AM filament (NT1 HC) and a 10-percent carbon fiber reinforced KetaSpire® PEEK AM filament (CF10 HC), together with a neat Radel® polyphenylsulfone (PPSU) AM filament (NT1 HC) are Solvay’s first medical grade AM filaments for limited contact applications (<24hr bodily="" br="" contact="" fluid="" tissue="">
Christophe Schramm, Additive Manufacturing business manager at Solvay’s Specialty Polymers global business unit (GBU), said:
“The healthcare industry is quickly emerging as a leading market to benefit from AM technology which makes customized parts for single use or low volumes possible. However, there is still a very limited choice of high-performance filaments that meet the stringent regulatory requirements in healthcare and this is the gap we want to close with our new selection of medical grade products.”
24hr>
Jeff Hrivnak, global business manager for Healthcare at Solvay’s Specialty Polymers GBU, said:
“These new medical grade AM filaments emphasize Solvay’s continuing, pro-active initiatives to support our customers. The filaments can be used for a range of healthcare applications such as patient-specific cutting guides for surgery and for complex components in single-use and reusable medical devices.”
® KetaSpire and Radel are registered trademarks of Solvay.
Source: Solvay
Medical-grade AM Filaments
A neat KetaSpire® polyetheretherketone (PEEK) AM filament (NT1 HC) and a 10-percent carbon fiber reinforced KetaSpire® PEEK AM filament (CF10 HC), together with a neat Radel® polyphenylsulfone (PPSU) AM filament (NT1 HC) are Solvay’s first medical grade AM filaments for limited contact applications (<24hr bodily="" br="" contact="" fluid="" tissue="">
Christophe Schramm, Additive Manufacturing business manager at Solvay’s Specialty Polymers global business unit (GBU), said:
“The healthcare industry is quickly emerging as a leading market to benefit from AM technology which makes customized parts for single use or low volumes possible. However, there is still a very limited choice of high-performance filaments that meet the stringent regulatory requirements in healthcare and this is the gap we want to close with our new selection of medical grade products.”
24hr>
KetaSpire® PEEK & Radel® PPSU AM Filaments
- Solvay’s KetaSpire® PEEK AM filaments are designed to allow excellent fusion of printed layers, enable high part density and deliver exceptional part strength, including along the z-axis.
- Radel® PPSU AM filaments also provide excellent fusion of printed layers in addition to transparency, high elongation and toughness.
Jeff Hrivnak, global business manager for Healthcare at Solvay’s Specialty Polymers GBU, said:
“These new medical grade AM filaments emphasize Solvay’s continuing, pro-active initiatives to support our customers. The filaments can be used for a range of healthcare applications such as patient-specific cutting guides for surgery and for complex components in single-use and reusable medical devices.”
® KetaSpire and Radel are registered trademarks of Solvay.
Source: Solvay




Supporting Anticipated Production Activities
Hexagon is currently developing the tanks to support anticipated production activities as early as the 2020 timeframe. Production is planned to run for at least five years. Hexagon estimates the combined value for development and serial production to be in the range of USD 50 to 70 million (approximately NOK 0.4 billion to 0.6 billion).
Rick Rashilla, Senior Vice President of Hexagon Composites' Hydrogen Automotive business, said:
"This is a major contract for Hexagon and for the growing FCEV industry. Hexagon Composites is committed to investing resources into the success of this project and for the adoption of Hydrogen in combination with fuel-cell technology as a low-carbon alternative fuel for mobility applications. This selection further confirms our leading position as a light duty hydrogen tank developer for the FCEV industry."